» Articles » PMID: 12475835

Patterns of Inhaled Asthma Medication Use: a 3-year Longitudinal Analysis of Prescription Claims Data from British Columbia, Canada

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2002 Dec 12
PMID 12475835
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objectives: To assess trends in asthma management and to identify factors associated with increasing short-acting (SA) beta-agonist utilization in British Columbia using administrative prescription data.

Design: A retrospective cohort analysis.

Setting: All patients between 13 and 50 years of age who had received at least one prescription for a SA beta-agonist covered by BC Pharmacare between January 1, 1996, and December 31, 1998.

Methods: Cross-sectional analysis of all patients, and longitudinal analyses only of patients who had received at least one SA beta-agonist prescription in each of the 3 years. Trends in asthma medication use over time were evaluated using repeated-measures Mantel-Haenszel tests. Multiple logistic regression was used to identify factors associated with increasing SA beta-agonist use.

Results: A total of 78,758 patients were included in the cohort. No decrease in the annual prevalence of receiving more than four canisters per year of a SA beta-agonist was identified between 1996 and 1998. A total of 12,844 patients filled at least one SA beta-agonist prescription each year. Time-trend analysis showed an overall increasing probability of not receiving an inhaled corticosteroid (ICS) agent in this population (p = 0.002). In patients exhibiting low SA beta-agonist use, > 18 years of age (adjusted odds ratio [OR], 1.5), male gender (adjusted OR, 1.7), and in receipt of social assistance (adjusted OR, 2.3) were associated with receiving increasing amounts of SA beta-agonist agents over the 3 years. In patients with a high degree of use of SA beta-agonists, only the receipt of social assistance (adjusted OR, 1.3) was significantly associated with increasing use.

Conclusions: Despite the development and dissemination of asthma management guidelines, there was no trend toward decreasing SA beta-agonist use. An unexpected trend toward decreasing ICS utilization was identified. Receiving social assistance was a risk factor for increasing SA beta-agonist use, independent of baseline utilization.

Citing Articles

[Association between the use of short-acting bronchodilators and the risk of hospitalization for asthma in a real-life clinical practice population cohort].

Sorribas Morlan M, Galmes Garau M, Esteva Canto M, Leiva Rus A, Roman-Rodriguez M Aten Primaria. 2020; 52(9):600-607.

PMID: 32571597 PMC: 7713391. DOI: 10.1016/j.aprim.2020.03.004.


Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study.

Tavakoli H, FitzGerald J, Lynd L, Sadatsafavi M BMC Pulm Med. 2018; 18(1):33.

PMID: 29433489 PMC: 5809893. DOI: 10.1186/s12890-018-0598-4.


ASSESSMENT OF SOCIOECONOMIC STATUS AND CONTROL OF ASTHMA IN ADULTS.

Azeez I, Ladipo M, Ige O Ann Ib Postgrad Med. 2017; 14(2):85-91.

PMID: 28337093 PMC: 5354626.


Quality of asthma care under different primary care models in Canada: a population-based study.

To T, Guan J, Zhu J, Lougheed M, Kaplan A, Tamari I BMC Fam Pract. 2015; 16:19.

PMID: 25886504 PMC: 4336688. DOI: 10.1186/s12875-015-0232-y.


Direct health care costs associated with asthma in British Columbia.

Sadatsafavi M, Lynd L, Marra C, Carleton B, Tan W, Sullivan S Can Respir J. 2010; 17(2):74-80.

PMID: 20422063 PMC: 2866215. DOI: 10.1155/2010/361071.